支气管动脉栓塞术前多排CT血管成像有助于检出责任异位支气管动脉及起源于锁骨下动脉和胸廓内动脉的非支气管体循环动脉,并提高咯血患者无咯血早期生存率
这项回顾性研究纳入2012年9月至2017年3月连续157例接受支气管动脉栓塞术的咯血患者,其中106例术前行MDCT血管成像、51例未行。MDCT组每例患者责任异位支气管动脉数(0.15±0.51 vs 0.04±0.20,p=0.022)及起源于锁骨下动脉和胸廓内动脉的非支气管体循环动脉数(0.17±0.56 vs 0.08±0.39,p=0.040)均显著高于对照组。MDCT组临床成功率有高于对照组的趋势(97.2% vs 88.2%,p=0.057),无咯血早期生存率显著高于对照组(96.1% vs 86.7%,p=0.031)。作者认为术前MDCT血管成像可作为咯血患者BAE前的常规检查推荐。
要点
- 术前MDCT血管成像可帮助检出责任异位支气管动脉及起源于锁骨下动脉和胸廓内动脉的非支气管体循环动脉。
- MDCT组无咯血早期生存率显著高于对照组(96.1% vs 86.7%,p=0.031)。
- MDCT组临床成功率有高于对照组的趋势(97.2% vs 88.2%,p=0.057),未达统计学显著。
核心结论
- 术前MDCT血管成像有助于在BAE中检出责任异位支气管动脉及起源于锁骨下动脉和胸廓内动脉的非支气管体循环动脉,并可提高无咯血早期生存率,作者认为可作为咯血患者BAE前的常规检查推荐。
研究设计与样本
- 回顾性研究,经机构审查委员会批准并豁免患者知情同意;2012年9月至2017年3月连续157例接受BAE的咯血患者,其中MDCT组106例术前行MDCT血管成像,对照组51例未行术前MDCT血管成像。
诊断标准与关键数值
- MDCT组每例患者责任异位支气管动脉数为0.15±0.51,对照组为0.04±0.20(p=0.022);MDCT组每例患者起源于锁骨下动脉和胸廓内动脉的非支气管体循环动脉数为0.17±0.56,对照组为0.08±0.39(p=0.040)。
临床应用与阅片要点
- 作者认为术前MDCT血管成像可作为咯血患者BAE前的常规检查推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare the average number of culprit arteries per patient, clinical success rate, and hemoptysis-free survival rate between hemoptysis patients with multidetector computed tomography (MDCT) angiography prior to bronchial artery embolization (BAE) and those without preprocedural MDCT angiography METHODS: This retrospective study was approved by the institutional review board with waiver of patient informed consent. From September 2012 to March 2017, 157 consecutive hemoptysis patients had been undergoing BAE. Among them, 106 patients received preprocedural MDCT angiography (MDCT group), while 51 patients did not receive preprocedural MDCT angiography (control group). The average number of culprit arteries per patient, clinical success rate, and hemoptysis-free survival rate were compared between the two groups.
RESULTS: The average number of culprit ectopic bronchial arteries and that of non-bronchial systemic arteries originating from the subclavian and internal mammary arteries per patient in the MDCT group were both significantly higher than those in the control group (0.15 ± 0.51 vs 0.04 ± 0.20, p = 0.022, and 0.17 ± 0.56 vs 0.08 ± 0.39, p = 0.040, respectively). The clinical success rate of BAE with preprocedural MDCT angiography tended to be higher than that without MDCT angiography (97.2 vs 88.2%, p = 0.057). Importantly, patients in the MDCT group had a significantly higher hemoptysis-free early survival rate compared to those in the control group (96.1 vs 86.7%, p = 0.031).
CONCLUSIONS: Preprocedural MDCT angiography helps detect culprit ectopic bronchial arteries and non-bronchial systemic arteries originating from subclavian and internal mammary arteries during BAE, and can improve the hemoptysis-free early survival rate, which could be recommended as a regular examination prior to BAE in patients with hemoptysis.
KEY POINTS: • Preprocedural MDCT angiography helps detect culprit ectopic bronchial arteries and NBSAs originating from subclavian and internal mammary arteries during BAE. • Conducting MDCT angiography prior to BAE can improve hemoptysis-free early survival rate in hemoptysis patients.
引用
- Li PJ, Yu H, Wang Y, et al. Multidetector computed tomography angiography prior to bronchial artery embolization helps detect culprit ectopic bronchial arteries and non-bronchial systemic arteries originating from subclavian and internal mammary arteries and improve hemoptysis-free early survival rate in patients with hemoptysis. Eur Radiol. 2018. PMID: 30324381. doi:10.1007/s00330-018-5767-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。